Time

Subject

Moderator

8:00-8:30

Continental breakfast

8:30-8:40

Welcome and introduction of meeting program

Jutta Preiksaitis /

8:40-9:30

Close session:
Review of  2006 Consensus statements
1.      CAHCLS will initiate a discussion to rationalize
         tissue/organ/cells donor testing across the country.
2.      We will continue to work collectively and with Abbott
         (David) to pinpoint the source of the problem, through
         research, data and sample sharing.
3.      We propose to establish a working group to examine
         the utility of finding an algorithm that could eliminate
         the need for WB.
4.      CAHCLS representative to attend the CATIE AGM. 
         CAHCLS will continue communications with CATIE
         to distribute information to persons living with
         HIV\AIDS (PHAS) and those supporting (PHAS).
5.      Consensus statement regarding HIV test kit
         licensure regulations is with Debbie and Maria.
6.      To carry out post market surveillance of all HIV kits
         for donor screening, diagnosis and care.
 

9:30-10:10

Open session:

Invited speaker:

Dr. Robert (Bob) Coombs

Chris Sherlock

10:10-10:25

Refreshment break

10:25-10:45

Closed session:

Topics for discussion:

-     -  Abbott AxSym HIV Go1/2

Carol Swantee &
Darrel Cook

10:45-11:10

Closed session: HIV diagnostic testing issues

PRESENTATION: C Claessens - Data on Innolia

Carol Swantee &
Darrel Cook

Closed session: HIV diagnostic testing issues

Topics for discussion:

-     -     "4th generation-Ab/Ag" assays and availability only on
      'Architect'

-     -     Experience with other HIV EIA screen: e.g. Bayer

Closed session: HIV diagnostic testing issues

PRESENTATION: Bonita Lee - Rapid HIV testing program in Alberta

Topics for discussion:

-      -    Rapid HIV updates – update the status in each

            province and any testing issue

-     Med-Mira rapid HIV test kits

12:00-1:00

Lunch

1:00 – 1:45

Closed session: HIV diagnostic testing issues

PRESENTATION: C Sherlock\L Merrick - Data on HIV Viral Load comparison on new commercial systems.

Topics for discussion:

-      -    New HIV viral load assays

-      -    APTIMA GenProbe assay recently approved in the US
      as confirmation testing (T Hatchette.)

-      -    HIV-2 viral load testing availability (F Sidaway)

Carol Swantee &
Darrel Cook

Closed session: HIV diagnostic testing issues

Topics for discussion:

-      -    HIV genotyping on a drug naive patient (M Dawood)

-      -    HIV Therapeutic Drug Monitoring (TDM) (F Sidaway)

Open session:

PRESENTATION: Gail McNabb - Data on Cadaver testing on Bayer system (HIV & HBsAg)

2:30 – 3:00

Open session:

PRESENTATION: J Kim\D Cook\C Swantee - HTLV antibodies

Topics for discussion:

-     -     HTLV confirmatory testing

3:00 – 3:15

Refreshment break

3:15 - 4:05

Open session:

Industry scientific presentation

Roche Diagnostics –  Speaker and title to be announced

Chris Sherlock

Close session:

One-on-one with industry: Roche Diagnostics

Close session:

One-on-one with industry: Siemens Scientific Affairs (Bayer)

Close session:

One-on-one with industry: Abbott Molecular and Diagnostics

Close session:

One-on-one with industry: Biolytical

6:30 Bus at entrance of hotel

SOCIAL EVENT: Fort Edmonton Park
                    
 

Time

Subject

Moderator

8:00 - 8:30

Continental breakfast

8:30 - 9:20

Open session:

Industry scientific presentation

Siemens Scientific Affairs (Bayer) – Dr. Katherine Soreng  (Clinical Scientific Affairs) - Diagnostic testing in the management of HIV

Chris Sherlock

9:20 - 10:10

Open session:

Industry scientific presentation

Abbott Molecular and Diagnostics – Dr. John Hackett - "HIV Surveillance: Monitoring the Global Diversification of HIV and the Emergence of New Variants"

10:10 -1 0:25

Refreshment break

10:25 - 10:55

Open session:

Industry scientific presentation

Biolytical – Rick Galli – HIV POC testing

Chris Sherlock

10:55 - 11:15

Closed session:

PRESENTATION: Barry Plant - "A Proposed CAHCLS and CATIE Partnership"

Carol Swantee

11:15 - 11:45

Closed session:

PRESENTATION: James Brooks - Federal HIV genotype surveillance

Topics for discussion:

Federal HIV genotype surveillance (Paul Levett)

Carol Swantee

11:45 - 12:45

Lunch

12:45 - 1:15

Closed session:

PRESENTATION: John Kim - NHIVRL review

Darrel Cook

Closed session:

PRESENTATION: Debbie Lepine - Health Canada TPP report on new kits, regulations, FDA\Canadian approval and Post-marketing surveillance

Closed session: HIV diagnostic testing issues

To be continued from yesterday

2:45 - 3:00

Refreshment break

3:00 - 4:00

Closed session:

HIV diagnostic testing issues & Consensus statement:

John Kim

4:00 - 5:00

Closed session:

CAHCLS business meeting

Chris Sherlock